UROVYSION for Bladder Cancer – (Fluorescence in-situ Hybridization (FISH))

By: | Tags: | Comments: 0 | October 29th, 2019

Approved for NJ and NY

UROVYSION – Urovysion™ is a sensitive and specific test used to diagnose urothelial carcinoma in urine. UroVysion has been approved by the FDA for both monitoring of patients with a history of bladder cancer and detection in patients with hematuria.

Lincoln Labs UroVysion Analysis offers:

  • Turnaround time of 7-10 days
  • Broad coverage by most private and public insurance.

Specimen Requirements

Specimen Collection – Urine Volume 33 mL urine mixed with 17 mL preservative (PreserveCyt) in Urine Collection/Cytology   kit Container

  • Use a large, open cup in the kit to collect the urine specimen. Second void of the day is preferred.
  • Slowly pour urine into two smaller PreserveCyt containers to the maximum fill.
  • Tighten the lid until you hear a click in order to prevent leakage.

Leave a Reply

5 + 14 =